Beskrovnaya Oxana — SEC Form 4 filings
SEC reporting owner CIK 1824542. 14 Form 4 filings on record with FilingPulse; latest filed 2025-03-13.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-03-11 to 2025-03-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 17 legs across 13 filings — 57,892 shares, $1,749,509 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
- Largest priced transaction: sale of 17,134 shares @ $32.49 ($556,684) in Dyne Therapeutics, Inc., filed 2024-05-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | Chief Scientific Officer | 14 | — | 17 legs · 57,892 sh · $1,749,509 | 5 |
Form 4 filings — Beskrovnaya Oxana
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-03-13 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 2,153 @ $11.38 | EDGAR |
| 2025-03-07 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 1,094 @ $11.83 | EDGAR |
| 2025-02-25 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 2,598 @ $13.95 | EDGAR |
| 2024-12-11 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 2,334 @ $28.12 | EDGAR |
| 2024-12-06 | 4 | Dyne Therapeutics, Inc. (DYN) | Grant/award (A): 39,100 @ $0 · Grant/award (A): 27,400 @ $0 · Grant/award (A): 62,400 (derivative) @ $0 | EDGAR |
| 2024-11-18 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 2,856 @ $28.20 | EDGAR |
| 2024-09-19 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 2,339 @ $34.55 | EDGAR |
| 2024-09-11 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 2,161 @ $31.89 | EDGAR |
| 2024-08-20 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 2,340 @ $45.01 · Sale (S): 296 @ $46 | EDGAR |
| 2024-06-11 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 2,136 @ $31.34 | EDGAR |
| 2024-05-22 | 4 | Dyne Therapeutics, Inc. (DYN) | Option exercise (M): 30,426 @ $1.03 · Sale (S): 17,134 @ $32.49 · Sale (S): 12,147 @ $33.51 · Sale (S): 1,145 @ $34.08 · Option exercise (M): 30,426 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 2,222 @ $28.20 · Sale (S): 483 @ $28.59 | EDGAR |
| 2024-03-12 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 2,081 @ $25.70 | EDGAR |
| 2024-03-11 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 2,373 @ $25.85 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1824542 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →